The Defense Logistics Agency is planning a fully competitive, firm-fixed price requirements contract for Ondansetron tablets. The contract will have a one-year base period and four one-year option periods to establish a national supply source for several federal agencies. The performance of services is national in scope, supporting customers through DLA and VA prime vendor programs. The projected solicitation date is March 2023, though the agency reserves the right to issue it before or after that date.